Gautam Patel, Director at Amneal Pharmaceuticals, Inc. (AMRX), bought 50,000 shares at $4.21 ($211K) on 2021-12-17, disclosed to the SEC on 2021-12-20.
Open-market purchase of $210k AMRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| AMRX | SELL | 2025-05-06 | $69K | — | Filing → |
| AMRX | SELL | 2025-04-02 | $664K | — | Filing → |
| AMRX | SELL | 2025-03-05 | $712K | — | Filing → |